Dermatology · Omaha, NE
NPI
1528217395
Since 2008
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
8601 West Dodge Rd., Ste #240
Omaha, NE, 68114
Phone (402) 933-0800
Groups this clinician bills Medicare through
Medicare paid, 2024
$458K
9,842 services
Medicare patients, 2024
2,206
Average age 76
Drug cost, 2024
$696K
2,307 prescriptions
Company payments, 2024
$20.52
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Justin G Madson was code 17003 (destruction skin lesion), 3,281 times for 727 patients. In total Justin G Madson billed 9,842 services in 101 codes, and Medicare paid $458K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-05-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 3,281 | 727 | $4.49 | $15K |
| 17000 Destruction Skin Lesion | Office | 1,322 | 1,056 | $36.01 | $48K |
| 99213 Office E&M - Established | Office | 1,268 | 1,091 | $56.67 | $72K |
| 99212 Office E&M - Established | Office | 1,030 | 895 | $35.67 | $37K |
| 17110 Destruction Skin Lesion | Office | 636 | 579 | $73.21 | $47K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 370 | 68 | $0.69 | $255 |
| 88305 Surgical Pathology Examination | Office | 270 | 207 | $51.02 | $14K |
| 11102 Skin Biopsy | Office | 228 | 213 | $54.09 | $12K |
| 17311 Mohs Surgery | Office | 142 | 129 | $479.89 | $68K |
| 99203 Office E&M - New | Office | 138 | 138 | $68.21 | $9,413 |
| 99202 Office E&M - New | Office | 127 | 127 | $41.88 | $5,319 |
| 17312 Mohs Surgery | Office | 110 | 78 | $322.19 | $35K |
| 96372 Injection Administration | Office | 45 | 36 | $9.83 | $442 |
| 12032 Wound Repair - All Levels | Office | 44 | 41 | $171.00 | $7,524 |
| 17111 Destruction Skin Lesion | Office | 44 | 40 | $80.78 | $3,554 |
By year: 2022 $453K for 10,668 services; 2023 $439K for 10,357 services; 2024 $458K for 9,842 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 88305 Surgical Pathology Examination | 270 | 207 | $51.02 | $14K |
| 88304 Surgical Pathology Examination | 36 | 30 | $32.87 | $1,183 |
| 36415 Venipuncture Blood Collection | 14 | 11 | $7.84 | $110 |
Medicare prescription drug claims, 2024
In 2024, the drug Justin G Madson prescribed most often to Medicare patients was Triamcinolone Acetonide, with 392 prescriptions and refills. In total Justin G Madson wrote 2,307 Medicare prescriptions that cost $696K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Triamcinolone Acetonide Generic | 392 | 438 | 234 | $6,207 |
| Clobetasol Propionate Generic | 268 | 300 | 146 | $15K |
| Doxycycline Hyclate Generic | 152 | 209 | 37 | $3,400 |
| Hydrocortisone Generic | 144 | 152 | 86 | $1,168 |
| Minoxidil Generic | 132 | 207 | 29 | $1,154 |
| Ketoconazole Generic | 129 | 145 | 77 | $3,451 |
| Methotrexate Methotrexate Sodium | 114 | 167 | 23 | $1,755 |
| Betamethasone Dipropionate Generic | 105 | 105 | 45 | $3,953 |
| Finasteride Generic | 87 | 172 | 19 | $663 |
| Fluorouracil Generic | 86 | 89 | 71 | $6,953 |
| Metronidazole Generic | 53 | 59 | 26 | $2,635 |
| Mometasone Furoate Generic | 43 | 44 | 30 | $913 |
| Prednisone Generic | 41 | 55 | 17 | $169 |
| Humira(Cf) Pen Adalimumab | 40 | 40 | Under 11 | $375K |
| Mirtazapine Generic | 40 | 58 | Under 11 | $1,078 |
Brand drugs: - claims; generic drugs: 2,197 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Justin G Madson $20.52 ($20.52 in general payments such as food, travel and fees) from 1 company. The largest payer was Kerecis Limited with $20.52.
| Company | Payments | Amount |
|---|---|---|
| Kerecis Limited | 1 | $20.52 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.